8102
-
Biologics: Targets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Biologics: Targets and Therapy
(1,101,171) Views
Editor in Chief Dr Doris Mangiaracina Benbrook
1177-5475
Advanced ovarian cancer: Vaccination site draining lymph node as target of immuno-modulative adjuvants in autologous cancer vaccine
Eduardo Lasalvia-Prisco, Emilio Garcia-Giralt, Silvia Cucchi, Jesús Vázquez, Leonard Robinson, et al
Biologics: Targets and Therapy 2007, 1:173-181
30 November 2007
Infliximab in the treatment of ankylosing spondylitis
Rebecca Grainger, Andrew A Harrison
Biologics: Targets and Therapy 2007, 1:163-171
30 November 2007
Biological targets for isatin and its analogues: Implications for therapy
Alexei Medvedev, Olga Buneeva, Vivette Glover
Biologics: Targets and Therapy 2007, 1:151-162
30 November 2007
Dishing the dirt on asthma: What we can learn from poor hygiene
Catherine de Lara, Alistair Noble
Biologics: Targets and Therapy 2007, 1:139-150
30 November 2007
Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders
Ruben A Mesa
Biologics: Targets and Therapy 2007, 1:129-138
30 November 2007
Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance
Giovanni Martinelli, Ilaria Iacobucci, Simona Soverini, Francesca Palandri, Fausto Castagnetti et al
Biologics: Targets and Therapy 2007, 1:121-127
30 November 2007
Radioimmunotherapy with tositumomab and iodine-131 tositumomab for non-Hodgkin's lymphoma
Biree Andemariam, John P Leonard
Biologics: Targets and Therapy 2007, 1:113-120
30 April 2007
The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT
Andreas Koster, Karl-Georg Fischer, Sebastian Harder, Fritz Mertzlufft
Biologics: Targets and Therapy 2007, 1:105-112
30 November 2007
Drug focus: adalimumab in the treatment of moderate to severe psoriasis
Gino A Vena
Biologics: Targets and Therapy 2007, 1:93-103
30 November 2007
Cetuximab in the management of colorectal cancer
Heinz-Josef Lenz
Biologics: Targets and Therapy 2007, 1:77-91
30 November 2007
Editorial: Evidence is steadily accumulating that ... || FREE PAPER ||
Sanjay Awasthi
Biologics: Targets and Therapy 2007, 1:75-76
30 November 2007
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Journal Indexing
See where all the Dove Press journals are indexed
